Healthcare Sector Ideas

[gfp927z]

DexCom - >>> Diabetes is a growing concern for the healthcare industry as the disease is related to many other health problems. And while 28.7 million people have been diagnosed with diabetes in the U.S., according to data from the Centers for Disease Control and Prevention (CDC), there's another 8.5 million people that it estimates are undiagnosed. An estimated 38% of the adult U.S. population has pre-diabetes, which in many cases will end up resulting in diabetes.


https://www.fool.com/investing/2023/04/13/2-stocks-turned-40000-into-1-million-in-10-years/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article


DexCom, which makes continuous glucose monitoring (CGM) devices that help people stay on top of their blood glucose levels, has made for a phenomenal growth investment over the years. In the past decade the company's top line has soared, and the business is now consistently profitable as well.

The company's future looks bright as DexCom is always coming out with newer, smaller devices to help make monitoring glucose levels easier than before. Late last year, the Food and Drug Administration approved the company's G7 device for use in all types of diabetes, for anyone two years of age and older. The new device is 60% smaller than the previous iteration, and DexCom calls it "the most accurate CGM cleared by the FDA."

Investing $40,000 into the stock a decade ago would have been enough to get your investment to over $1 million today. It was a much riskier stock back then; in 2012, DexCom was coming off a year when sales were $100 million, and its net loss of $54.5 million was more than half of its top line.

Today, DexCom is a much safer investment, and while it may not produce the same kinds of returns over the next decade, this is still a great stock to buy and hold, given the ongoing need to manage diabetes.

<<<



---